| Literature DB >> 30410793 |
Hao-Chen Guo1, Wan-Qing Jin1, An-Peng Pan1, Qin-Mei Wang1, Jia Qu1, A-Yong Yu1.
Abstract
PURPOSE: To assess the changes and the diurnal variation of visual quality after orthokeratology in myopic children.Entities:
Year: 2018 PMID: 30410793 PMCID: PMC6205316 DOI: 10.1155/2018/3174826
Source DB: PubMed Journal: J Ophthalmol ISSN: 2090-004X Impact factor: 1.909
The orthokeratology lens parameters in this study.
| Brand | E&E | Euclid | Lucid |
|---|---|---|---|
| Origin | China | USA | Korea |
| Material | Boston XO | Boston equalens II | Boston XO |
| Dk (cm2/sec) (mL·O2/mL·mmHg) (ISO/fatt) | 100 ∗ 10–11 | 90 ∗ 10–11 | 140 ∗ 10–11 |
| The overall diameter (mm) | 10.6 | 10.6 | 10.6 |
| The optic zone diameter (mm) | 6 | 6.2 | 6.2 |
| The reverse curve (mm) | 0.6 | 0.5 | 0.9 |
| The anchor curve (mm) | 1.3 | 1.2 | 0.8 |
| The peripheral curve (mm) | 0.4 | 0.5 | 0.5 |
| The central thickness (mm) | 0.22 | 0.22 | 0.23 |
Figure 1Instantaneous map. ∗The instantaneous map calculates the corneal curvature radiuses from the shape between the infinitesimal intervals along meridians reflecting more local corneal curvatures (shapes).
Effects of orthokeratology on refraction and corneal curvature (n=22 eyes, mean ± SD).
| Time | Sphere (D) | Cylinder (D) | K1 (D) | K2 (D) |
|---|---|---|---|---|
| AM baseline | −3.83 ± 0.97 | −0.47 ± 0.43 | 42.05 ± 1.26 | 43.19 ± 1.37 |
| AM 1 month | −1.03 ± 0.85 | −0.69 ± 0.57 | 39.75 ± 0.97 | 40.64 ± 1.27 |
| PM 1 month | −1.10 ± 0.68 | −0.66 ± 0.52 | 40.02 ± 1.05 | 40.95 ± 1.27 |
| P1 | <0.001 | 0.155 | <0.001 | <0.001 |
| P2 | 0.568 | 0.500 | <0.001 | <0.001 |
Paired t-test. P1: comparison between AM baseline and AM 1 month after orthokeratology; P2: comparison between AM and PM during the same day 1 month after orthokeratology; K1: flat keratometric value; K2: steep keratometric value.
Effects of orthokeratology on OSI, TFM-OSI, MTF cut-off, SR, and OVs (n=22 eyes, mean ± SD).
| Time | OSI | TFM-OSI | MTF | SR | OVs-100% | OVs-20% | OVs-9% |
|---|---|---|---|---|---|---|---|
|
| |||||||
| AM baseline | — | — | 48.332 ± 8.10 | 0.309 ± 0.07 | 1.611 ± 0.27 | 1.778 ± 0.40 | 1.922 ± 0.49 |
| AM 1 month | — | — | 38.812 ± 9.58 | 0.225 ± 0.07 | 1.294 ± 0.32 | 1.292 ± 0.41 | 1.316 ± 0.46 |
| PM 1 month | — | — | 42.225 ± 8.93 | 0.250 ± 0.07 | 1.408 ± 0.30 | 1.448 ± 0.42 | 1.489 ± 0.48 |
| P1 | — | — | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| P2 | — | — | 0.067 | 0.064 | 0.068 | 0.053 | 0.068 |
|
| |||||||
|
| |||||||
| AM baseline | 0.295 ± 0.15 | 0.572 ± 0.29 | 46.089 ± 7.26 | 0.280 ± 0.05 | 1.537 ± 0.24 | 1.652 ± 0.35 | 1.733 ± 0.38 |
| AM 1 month | 0.652 ± 0.31 | 1.212 ± 0.97 | 37.312 ± 8.16 | 0.211 ± 0.05 | 1.244 ± 0.27 | 1.216 ± 0.33 | 1.233 ± 0.35 |
| PM 1 month | 0.712 ± 0.43 | 1.128 ± 0.59 | 38.856 ± 9.55 | 0.223 ± 0.06 | 1.295 ± 0.32 | 1.300 ± 0.41 | 1.325 ± 0.45 |
| P1 | <0.001 | 0.002 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 |
| P2 | 0.239 | 0.63 | 0.32 | 0.169 | 0.326 | 0.204 | 0.189 |
|
| |||||||
|
| |||||||
| AM baseline | — | — | 44.812 ± 8.87 | 0.275 ± 0.06 | 1.494 ± 0.30 | 1.602 ± 0.40 | 1.687 ± 0.46 |
| AM 1 month | — | — | 37.174 ± 7.96 | 0.215 ± 0.05 | 1.239 ± 0.27 | 1.209 ± 0.32 | 1.243 ± 0.36 |
| PM 1 month | — | — | 39.124 ± 10.37 | 0.224 ± 0.06 | 1.304 ± 0.35 | 1.322 ± 0.44 | 1.339 ± 0.44 |
| P1 | — | — | 0.003 | 0.001 | 0.003 | 0.001 | 0.001 |
| P2 | — | — | 0.177 | 0.294 | 0.178 | 0.051 | 0.109 |
Paired t-test. P1: comparison between AM baseline and AM 1 month after orthokeratology; P2: comparison between AM and PM during the same day 1 month after orthokeratology.
Effects of orthokeratology on ocular aberrations (n=22 eyes, mean ± SD).
| Time | Coma | Trefoil | Tetrafoil | Sph | S3 | S4 | S5 | S6 | S7 | S8 |
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Baseline AM | 0.019 ± 0.01 | 0.044 ± 0.02 | 0.023 ± 0.01 | −0.004 ± 0.01 | 0.050 ± 0.02 | 0.028 ± 0.01 | 0.017 ± 0.01 | 0.017 ± 0.01 | 0.013 ± 0.01 | 0.011 ± 0.01 |
| 1 month AM | 0.049 ± 0.03 | 0.077 ± 0.04 | 0.037 ± 0.02 | 0.019 ± 0.02 | 0.099 ± 0.04 | 0.050 ± 0.02 | 0.029 ± 0.02 | 0.025 ± 0.02 | 0.018 ± 0.01 | 0.015 ± 0.01 |
| 1 month PM | 0.052 ± 0.03 | 0.081 ± 0.05 | 0.030 ± 0.03 | 0.023 ± 0.01 | 0.101 ± 0.06 | 0.046 ± 0.03 | 0.027 ± 0.02 | 0.019 ± 0.01 | 0.015 ± 0.01 | 0.013 ± 0.01 |
| P1 | <0.001 | 0.002 | 0.005 | <0.001 | <0.001 | <0.001 | <0.001 | 0.11 | 0.081 | 0.235 |
| P2 | 0.618 | 0.665 | 0.216 | 0.03 | 0.799 | 0.331 | 0.752 | 0.233 | 0.409 | 0.428 |
|
| ||||||||||
|
| ||||||||||
| Baseline AM | 0.043 ± 0.02 | 0.081 ± 0.03 | 0.035 ± 0.02 | −0.010 ± 0.02 | 0.095 ± 0.03 | 0.047 ± 0.02 | 0.033 ± 0.01 | 0.028 ± 0.01 | 0.022 ± 0.01 | 0.018 ± 0.01 |
| 1 month AM | 0.196 ± 0.09 | 0.136 ± 0.08 | 0.072 ± 0.03 | 0.099 ± 0.06 | 0.256 ± 0.10 | 0.143 ± 0.06 | 0.087 ± 0.04 | 0.060 ± 0.03 | 0.039 ± 0.03 | 0.033 ± 0.03 |
| 1 month PM | 0.210 ± 0.08 | 0.145 ± 0.08 | 0.062 ± 0.05 | 0.108 ± 0.04 | 0.264 ± 0.10 | 0.141 ± 0.06 | 0.083 ± 0.05 | 0.046 ± 0.02 | 0.031 ± 0.02 | 0.026 ± 0.02 |
| P1 | <0.001 | 0.005 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.001 | 0.007 | 0.017 |
| P2 | 0.158 | 0.634 | 0.417 | 0.14 | 0.587 | 0.839 | 0.672 | 0.116 | 0.282 | 0.329 |
|
| ||||||||||
|
| ||||||||||
| Baseline AM | 0.091 ± 0.05 | 0.129 ± 0.04 | 0.059 ± 0.03 | −0.019 ± 0.05 | 0.166 ± 0.05 | 0.091 ± 0.04 | 0.064 ± 0.03 | 0.047 ± 0.03 | 0.039 ± 0.02 | 0.032 ± 0.02 |
| 1 month AM | 0.532 ± 0.26 | 0.223 ± 0.10 | 0.120 ± 0.06 | 0.333 ± 0.16 | 0.603 ± 0.26 | 0.393 ± 0.15 | 0.181 ± 0.09 | 0.112 ± 0.05 | 0.082 ± 0.05 | 0.065 ± 0.04 |
| 1 month PM | 0.540 ± 0.24 | 0.222 ± 0.10 | 0.093 ± 0.07 | 0.328 ± 0.14 | 0.602 ± 0.24 | 0.373 ± 0.14 | 0.157 ± 0.08 | 0.095 ± 0.05 | 0.074 ± 0.04 | 0.051 ± 0.03 |
| P1 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.001 | 0.002 |
| P2 | 0.762 | 0.969 | 0.181 | 0.73 | 0.968 | 0.224 | 0.238 | 0.233 | 0.536 | 0.213 |
Paired t-test. P1: comparison between AM baseline and AM 1 month after orthokeratology; P2: comparison between AM and PM during the same day 1 month after orthokeratology.
Effects of orthokeratology on corneal aberrations (n=22 eyes, mean ± SD).
| Time | Coma | Trefoil | Tetrafoil | Sph | S3 | S4 | S5 | S6 | S7 | S8 |
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Baseline AM | 0.048 ± 0.02 | 0.143 ± 0.05 | 0.105 ± 0.05 | 0.009 ± 0.01 | 0.155 ± 0.05 | 0.140 ± 0.05 | 0.091 ± 0.03 | 0.102 ± 0.03 | 0.063 ± 0.02 | 0.071 ± 0.02 |
| 1 month AM | 0.120 ± 0.09 | 0.210 ± 0.14 | 0.171 ± 0.10 | 0.026 ± 0.03 | 0.251 ± 0.16 | 0.243 ± 0.16 | 0.162 ± 0.10 | 0.184 ± 0.12 | 0.104 ± 0.06 | 0.129 ± 0.09 |
| 1 month PM | 0.109 ± 0.11 | 0.202 ± 0.14 | 0.170 ± 0.09 | 0.027 ± 0.02 | 0.242 ± 0.17 | 0.235 ± 0.15 | 0.149 ± 0.10 | 0.176 ± 0.12 | 0.097 ± 0.07 | 0.123 ± 0.09 |
| P1 | 0.002 | 0.047 | 0.011 | 0.003 | 0.015 | 0.005 | 0.005 | 0.003 | 0.01 | 0.004 |
| P2 | 0.663 | 0.836 | 0.946 | 0.924 | 0.825 | 0.81 | 0.616 | 0.77 | 0.666 | 0.761 |
|
| ||||||||||
|
| ||||||||||
| Baseline AM | 0.121 ± 0.05 | 0.452 ± 0.21 | 0.310 ± 0.11 | 0.038 ± 0.02 | 0.482 ± 0.19 | 0.413 ± 0.12 | 0.335 ± 0.11 | 0.314 ± 0.09 | 0.278 ± 0.12 | 0.221 ± 0.06 |
| 1 month AM | 0.534 ± 0.39 | 0.673 ± 0.42 | 0.604 ± 0.35 | 0.198 ± 0.17 | 0.903 ± 0.53 | 0.820 ± 0.46 | 0.657 ± 0.32 | 0.641 ± 0.35 | 0.468 ± 0.26 | 0.440 ± 0.24 |
| 1 month PM | 0.409 ± 0.40 | 0.561 ± 0.31 | 0.494 ± 0.34 | 0.200 ± 0.10 | 0.733 ± 0.49 | 0.696 ± 0.43 | 0.555 ± 0.30 | 0.533 ± 0.38 | 0.365 ± 0.25 | 0.357 ± 0.21 |
| P1 | <0.001 | 0.036 | <0.001 | <0.001 | 0.002 | <0.001 | <0.001 | <0.001 | 0.004 | <0.001 |
| P2 | 0.056 | 0.192 | 0.181 | 0.923 | 0.101 | 0.237 | 0.12 | 0.192 | 0.055 | 0.149 |
|
| ||||||||||
|
| ||||||||||
| Baseline AM | 0.411 ± 0.37 | 0.439 ± 0.39 | 0.330 ± 0.32 | 0.099 ± 0.15 | 0.668 ± 0.46 | 0.490 ± 0.45 | 0.645 ± 0.45 | 0.366 ± 0.30 | 0.497 ± 0.27 | 0.253 ± 0.20 |
| 1 month AM | 1.016 ± 0.42 | 1.175 ± 0.66 | 0.858 ± 0.53 | 0.451 ± 0.33 | 1.644 ± 0.62 | 1.454 ± 0.67 | 1.412 ± 0.69 | 1.266 ± 0.84 | 1.205 ± 0.83 | 1.042 ± 0.59 |
| 1 month PM | 1.231 ± 1.39 | 0.956 ± 1.12 | 0.738 ± 0.71 | 0.408 ± 0.37 | 1.629 ± 1.77 | 1.388 ± 1.38 | 1.182 ± 1.28 | 0.993 ± 0.99 | 0.918 ± 0.92 | 0.823 ± 0.89 |
| P1 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | <0.001 | 0.001 | <0.001 |
| P2 | 0.474 | 0.443 | 0.528 | 0.636 | 0.971 | 0.844 | 0.485 | 0.346 | 0.296 | 0.292 |
Paired t-test. P1: comparison between AM baseline and AM 1 month after orthokeratology; P2: comparison between AM and PM during the same day 1 month after orthokeratology.
Figure 2Effects of orthokeratology on ocular and corneal total aberrations (n=22 eyes).
Figure 3Effects of orthokeratology on ocular and corneal higher-order aberrations (n=22 eyes).
Effects of orthokeratology on contrast sensitive function (n=22 eyes, mean ± SD).
| Time | 3 cpd | 6 cpd | 12 cpd | 18 cpd | AULCSF |
|---|---|---|---|---|---|
|
| |||||
| AM baseline | 1.620 ± 0.19 | 1.677 ± 0.17 | 1.552 ± 0.21 | 1.266 ± 0.37 | 1.245 ± 0.10 |
| AM 1 month | 1.606 ± 0.16 | 1.700 ± 0.26 | 1.573 ± 0.29 | 1.272 ± 0.36 | 1.257 ± 0.16 |
| PM 1 month | 1.632 ± 0.12 | 1.706 ± 0.21 | 1.551 ± 0.34 | 1.408 ± 0.38 | 1.267 ± 0.15 |
| P1 | 0.706 | 0.634 | 0.7 | 0.913 | 0.659 |
| P2 | 0.342 | 0.87 | 0.654 | 0.002 | 0.655 |
|
| |||||
|
| |||||
| AM baseline | 1.636 ± 0.25 | 1.686 ± 0.24 | 1.483 ± 0.25 | 1.267 ± 0.37 | 1.235 ± 0.13 |
| AM 1 month | 1.577 ± 0.20 | 1.669 ± 0.32 | 1.517 ± 0.28 | 1.338 ± 0.35 | 1.235 ± 0.19 |
| PM 1 month | 1.613 ± 0.18 | 1.746 ± 0.22 | 1.562 ± 0.31 | 1.431 ± 0.38 | 1.285 ± 0.14 |
| P1 | 0.19 | 0.787 | 0.514 | 0.233 | 0.992 |
| P2 | 0.387 | 0.086 | 0.226 | 0.01 | 0.018 |
|
| |||||
|
| |||||
| AM baseline | 1.722 ± 0.17 | 1.657 ± 0.21 | 1.57 ± 0.29 | 1.266 ± 0.36 | 1.251 ± 0.13 |
| AM 1 month | 1.631 ± 0.14 | 1.716 ± 0.28 | 1.59 ± 0.27 | 1.397 ± 0.37 | 1.279 ± 0.17 |
| PM 1 month | 1.678 ± 0.14 | 1.775 ± 0.19 | 1.67 ± 0.22 | 1.430 ± 0.38 | 1.326 ± 0.11 |
| P1 | 0.006 | 0.317 | 0.746 | 0.012 | 0.431 |
| P2 | 0.115 | 0.129 | 0.017 | 0.371 | 0.01 |
Paired t-test. P1: comparison between AM baseline and AM 1 month after orthokeratology; P2: comparison between AM and PM during the same day 1 month after orthokeratology.